Pantoprazole Sodium Delayed-Release Tablets — Class II drug recall D-1058-2020
Terminated recall by Jubilant Cadista Pharmaceuticals, Inc., reported 2020-03-25, distributed nationwide. CGMP Deviations: Presence of dark brown discoloration on edges of tablets
| Recall number | D-1058-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, United States |
| Recall initiated | 2020-03-11 |
| Classified | 2020-03-24 |
| Reported by FDA | 2020-03-25 |
| Terminated | 2020-06-10 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 59746-0284-90 |
| Lot numbers | PA218005A, PA218108A, PA218110A, PA218P010, PA218P011 |
| Expiration dates | 2020-12, 2021-04, 2021-06 |
Product
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90
Reason for recall
CGMP Deviations: Presence of dark brown discoloration on edges of tablets
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1058-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.